Dulce Digital-Project Dulce 2.0 Texting Study

Dulce Digital-Project Dulce 2.0 Texting Study in High Risk Latinos With Diabetes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01749176

Enrollment

126

Registered

2012-12-13

Start date

2012-10-31

Completion date

2014-10-31

Last updated

2014-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

High risk Latino patients with diabetes

Brief summary

Randomized controlled trial testing the efficacy of a text messaging intervention in a low income, low health literacy group of Latino patients. Project Dulce 2.0 (PD 2.0) will address barriers to participation in health education classes, increasing adherence to treatment and medications and improving diabetes self management behaviors and skills. Two community clinic organizations that provide services to a large proportion of Latino patients with type 2 diabetes will participate to randomize 200 patients into one of 2 arms: standard diabetes management care (control) only or text messaging and standard care. Comparisons between groups will evaluate clinical, behavioral and psychosocial outcomes. Intervention: Standard Care and Text Messaging. All participants will receive standard diabetes care provided by primary care providers at the clinic. Of the 100 that are randomized to the intervention arm will be given instructions on how the text messaging component will be addressed throughout the duration of the study.

Interventions

BEHAVIORALSMS texting intervention

BEHAVIORALControl-Usual Care

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Ages 18-75, * Type 2 DM, * Enrolled at community health center, * Latino ethnicity, * non Project Dulce participant, * HbA1c\>/= 8%, must be able to read

Exclusion criteria

* Have a severe illness precluding frequent visits to the clinic, * have a severe medical condition, poor mental function or any other reason to expect patient difficulty in complying with the requirements of the study, any history of malignancy, except subjects who have been disease-free for \>10 years, or whose only malignancy has been basal or squamous cell skin carcinoma, * patients who have a creatinine level greater than 3.5, * any history of drug or alcohol abuse within 12 months prior to the study, * those who are not a permanent resident in the area. * Patients who are not willing to use a cell phone with texting capability.

Design outcomes

Primary

Measure	Time frame
HbA1c	6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026